Home
/ TiumBio
/ Competitors

TiumBio Competitors and Similar CompaniesClear all

TiumBio's competitors and similar companies include NED Biosystems, Astellas Pharma and SynDevRx.

	TiumBio TiumBio (주식회사 티움바이오) is a drug discovery company.	NED Biosystems NED Biosystems is a clinical-stage company developing cancer treatments as well as HIV/AIDS and diabetes treatments.	Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.	SynDevRx SynDevRx is a company dedicated to developing treatments for patients whose cancer is associated with metabolic dysfunction.
Founding Date	Founding Date 2016	Founding Date 2008	Founding Date 1923	Founding Date 2007
Type	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech diabetes drug development oncology pharma	Tags Healthcare biotech diabetes drug development oncology pharma	Tags Healthcare diabetes drug development oncology pharma	Tags Healthcare biotech diabetes drug development oncology pharma
Locations	Locations Seongnam, KR HQ	Locations Cambridge, US HQ	Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more	Locations Cambridge, US HQ
Employees	Employees 4213% decrease	Employees 6	Employees 14,754	Employees 8
Financial
Revenue (est.)	Revenue (est.) ₩6.8b (FY, 2024)	Revenue (est.) N/A	Revenue (est.) ¥2.1t (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥213.8b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit ₩9b (FY, 2024)	Gross profit N/A	Gross profit ¥2t (FY, 2026)	Gross profit N/A
Net income	Net income (₩23.5b) (FY, 2024)	Net income N/A	Net income ¥291.6b (FY, 2026)	Net income N/A
Funding
Total funding raised	Total funding raised $ 21.8m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 1.1m